• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during pregnancy and nursing is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these drugs can affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders such as hearing loss or impaired vision seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to consider the benefits of taking it against the possible risks for the baby. Physicians do not have the necessary data to give clear guidelines, but they can provide information on risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications during their early pregnancy did not face an increased risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large population-based study of case-control to determine the prevalence of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to confirm that the classification was correct and to minimize any bias.

However, the study was not without its flaws. Most important, they were not able to differentiate the effects of the medication from the disorder that is underlying. This limitation makes it difficult for researchers to determine whether the small associations observed among the groups that were exposed to the use of medications, or if they were affected by the presence of comorbidities. Additionally, the researchers did not look at the long-term outcomes of offspring.

The study found that infants whose mothers took ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to those whose mothers didn't take any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an increased risk of having a caesarean section or having a child with a low Apgar score (less than 7). These increases didn't appear to be affected by the type of medication that was used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both mother and child of continuing treatment for the woman's disorder. Physicians should speak with their patients about this and as much as possible, assist them develop coping skills that could reduce the impact of her disorder in her daily functioning and her relationships.

Interactions with Medication

Doctors are increasingly confronted with the dilemma of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are frequently taken without clear and authoritative evidence. Instead, doctors have to consider their own expertise and experience, as well as the experiences of other doctors and the research on the topic.

The issue of possible risks for infants can be difficult to determine. A lot of studies on this subject are based on observational evidence rather than controlled research and their conclusions are often contradictory. most effective adhd medication for adults uk studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects that can lead to terminations or abortions of pregnancy. The study discussed in this journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion is that while some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies demonstrate a neutral or slightly negative impact. As a result an accurate risk-benefit analysis is required in every situation.

It can you get adhd medication without a diagnosis be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. A decrease in medication could affect the ability to drive safely and complete work-related tasks, which are essential aspects of normal life for people with ADHD.

She recommends women who are uncertain about whether to continue or stop taking medication because of their pregnancy consider informing family members, friends, and coworkers on the condition, its effects on daily life, and the advantages of continuing the current treatment plan. It can also aid in ensuring that the woman feels supported in her struggle with her decision. Certain medications can pass through the placenta. If a woman decides to stop taking her ADHD best medication for anxiety depression and adhd while breastfeeding, it is important to be aware that the medication may be transferred to her infant.

Birth Defects and Risk of

As the use and abuse of ADHD medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) increases as does the concern about the potential effects of these drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Using two massive data sets, researchers were able to look at more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists found that exposure in the first trimester to ADHD medications was linked to a slightly higher rate of certain heart defects, such as ventriculo-septal defect (VSD).

The researchers of the study found no association between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The results are in line with previous studies revealing an increase, but not significant, in the risk of cardiac malformations in women who started taking ADHD medications prior to the time of the birth of their child. The risk increased in the latter stages of pregnancy when a large number of women began to stop taking their medication.

Women who took ADHD medication during the first trimester were more likely to require a caesarean birth and also have an insufficient Apgar after delivery and have a baby that needed help breathing when they were born. However, the authors of the study were not able to eliminate selection bias by restricting the study to women who didn't have any other medical conditions that could have contributed to these findings.

Researchers hope that their study will inform physicians when they see pregnant women. They advise that while the discussion of the risks and benefits is crucial but the decision to stop or maintain treatment must be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, while stopping the medication is a possibility to consider, it is not recommended because of the high incidence of depression and other mental problems in women who are expecting or recently gave birth. Furthermore, research suggests that women who choose to stop taking their medication are more likely to have a difficult time adapting to life without them following the baby's arrival.

Nursing

It can be a stressful experience to become a mom. Women who suffer from ADHD who have to deal with their symptoms while attending physician appointments as well as preparing for the arrival of a baby and adjusting to new household routines can experience severe challenges. Many women opt to continue taking their ADHD medication during pregnancy.

The risk to breastfeeding infant is minimal because the majority of stimulant medications is absorbed through breast milk at low levels. However, the rate of exposure to medication by the infant can differ based on dosage, frequency it is administered and the time of the day the medication is administered. In addition, various medications are introduced into the baby's system through the gastrointestinal tract or through breast milk. The impact of these medications on a newborn's health is not completely understood.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the absence types of adhd medication uk research. This is a difficult choice for the patient, who must weigh the benefit of continuing her medication against the possible dangers to the fetus. Until more information becomes available, doctors can ask pregnant patients whether they have an background of ADHD or if they intend to take medication in the perinatal period.

A growing number of studies have revealed that the majority of women are able to safely continue taking their ADHD medication while they are pregnant and nursing. In the end, more and more patients are choosing to do so and, in consultation with their physician, they have discovered that the benefits of maintaining their current medication far outweigh any risks.

Women with ADHD who are planning to nurse should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non stimulant adhd medication-pharmacological strategies. Psychoeducation is also needed to help pregnant women with ADHD understand the symptoms and underlying disorder. They should also be educated about treatment options and reinforce coping mechanisms. This should include an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and the child, and monitoring for indicators Types of Adhd medication deterioration, and, if necessary, adjustments to the medication regime.